The global induced pluripotent stem cells (iPSCs) market is witnessing several emerging trends and opportunities that are reshaping the landscape of regenerative medicine and driving innovation in the industry. One of the key trends in the iPSCs market is the growing application of iPSC-derived cell therapies for the treatment of degenerative diseases, genetic disorders, and other medical conditions with high unmet medical needs.
